Molecule Holdings Financials
| EVRRF Stock | USD 0 0.00 0.00% |
Molecule |
Understanding current and past Molecule Holdings Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Molecule Holdings' financial statements are interrelated, with each one affecting the others. For example, an increase in Molecule Holdings' assets may result in an increase in income on the income statement.
Molecule Holdings Stock Summary
Molecule Holdings competes with Atlas Corp, PureCycle Technologies, and GCM Grosvenor. Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It offers its beverage products under the PHRESH, embody, and CANAJO brands. Molecule Holdings is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 591 Reynolds Road, |
| Sector | Metals & Mining |
| Industry | Materials |
| Benchmark | Dow Jones Industrial |
| Website | www.molecule.ca |
| Phone | 613 809 1814 |
| Currency | USD - US Dollar |
Molecule Holdings Key Financial Ratios
There are many critical financial ratios that Molecule Holdings' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Molecule Holdings reports annually and quarterly.| Return On Equity | -10.88 | |||
| Return On Asset | -0.41 | |||
| Number Of Employees | 15 | |||
| Beta | -0.64 | |||
| Z Score | -5.0 |
Molecule Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Molecule Holdings's current stock value. Our valuation model uses many indicators to compare Molecule Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Molecule Holdings competition to find correlations between indicators driving Molecule Holdings's intrinsic value. More Info.Molecule Holdings is rated # 4 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Molecule Holdings' earnings, one of the primary drivers of an investment's value.Molecule Holdings Systematic Risk
Molecule Holdings' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Molecule Holdings volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourty-two with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on Molecule Holdings correlated with the market. If Beta is less than 0 Molecule Holdings generally moves in the opposite direction as compared to the market. If Molecule Holdings Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Molecule Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Molecule Holdings is generally in the same direction as the market. If Beta > 1 Molecule Holdings moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Molecule Pink Sheet analysis
When running Molecule Holdings' price analysis, check to measure Molecule Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecule Holdings is operating at the current time. Most of Molecule Holdings' value examination focuses on studying past and present price action to predict the probability of Molecule Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecule Holdings' price. Additionally, you may evaluate how the addition of Molecule Holdings to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |